HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sundari Firming Skin Care Formulated With Active Peptides, Gotu Kola

This article was originally published in The Rose Sheet

Executive Summary

Sundari Gotu Kola Firming Collection combines active peptides and Ayurvedic medicine to firm and lift skin, the company claims

You may also be interested in...



Marketing In Brief

Lancôme: Aroma Cool Awakening Body Treatment collection replenishes skin with Actipure, a natural extract of hibiscus blossom, as well as essential oils and natural extracts of citrus, jasmine and cedar, L'Oreal division says. Bowing this fall, range features treatment fragrance in 3.3 oz. bottle for $40, as well as moisturizing body milk, which will cost $27 for 6.7 oz. Lancôme launched sister collections Aroma Tonic and Aroma Fit in 1999 and 2001, respectively (1"The Rose Sheet" Jan. 18, 1999, p. 10 and 2"The Rose Sheet" June 18, 2001, p. 4)...

Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.

MADIT-CRT Data Support Expanded Cardiac Resynchronization Market

The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel